Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
$1.26
-3.1%
$1.19
$0.93
$3.42
$62.94M1.35385,582 shs106,893 shs
Singular Genomics Systems, Inc. stock logo
OMIC
Singular Genomics Systems
$20.01
$20.01
$5.34
$23.41
$50.83M1.8349,087 shsN/A
Optex Systems Holdings Inc. stock logo
OPXS
Optex Systems
$10.72
+3.6%
$7.82
$5.36
$11.20
$74.08M0.2528,215 shs231,246 shs
Precipio, Inc. stock logo
PRPO
Precipio
$11.51
+6.1%
$8.41
$3.90
$11.80
$17.38M1.289,575 shs5,550 shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
0.00%+2.44%0.00%-24.55%-46.61%
Singular Genomics Systems, Inc. stock logo
OMIC
Singular Genomics Systems
0.00%0.00%0.00%0.00%+90.35%
Optex Systems Holdings Inc. stock logo
OPXS
Optex Systems
0.00%+18.98%+29.31%+79.99%+45.85%
Precipio, Inc. stock logo
PRPO
Precipio
0.00%+6.07%+20.32%+68.26%+131.10%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
1.0972 of 5 stars
3.01.00.00.00.01.70.6
Singular Genomics Systems, Inc. stock logo
OMIC
Singular Genomics Systems
N/AN/AN/AN/AN/AN/AN/AN/A
Optex Systems Holdings Inc. stock logo
OPXS
Optex Systems
2.3948 of 5 stars
0.05.00.00.02.52.51.3
Precipio, Inc. stock logo
PRPO
Precipio
1.6753 of 5 stars
0.05.00.00.03.32.50.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
2.00
Hold$2.5198.89% Upside
Singular Genomics Systems, Inc. stock logo
OMIC
Singular Genomics Systems
2.00
Hold$6.50-67.52% Downside
Optex Systems Holdings Inc. stock logo
OPXS
Optex Systems
0.00
N/AN/AN/A
Precipio, Inc. stock logo
PRPO
Precipio
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest PRPO, AKYA, OPXS, and OMIC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/19/2025
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$1.80 ➝ $1.08
4/29/2025
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$3.50 ➝ $1.80
4/14/2025
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$2.40 ➝ $1.65
3/25/2025
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Equal Weight$3.50 ➝ $1.80
(Data available from 6/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
$81.67M0.77N/AN/A$0.15 per share8.40
Singular Genomics Systems, Inc. stock logo
OMIC
Singular Genomics Systems
$2.91M17.47N/AN/A$73.25 per share0.27
Optex Systems Holdings Inc. stock logo
OPXS
Optex Systems
$33.99M2.18$0.62 per share17.32$2.74 per share3.91
Precipio, Inc. stock logo
PRPO
Precipio
$18.53M0.94N/AN/A$8.16 per share1.41
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
-$55.37M-$0.97N/AN/AN/A-59.44%-487.85%-35.86%8/4/2025 (Estimated)
Singular Genomics Systems, Inc. stock logo
OMIC
Singular Genomics Systems
-$94.82M-$35.11N/AN/A-3,237.89%-57.87%-37.90%8/12/2025 (Estimated)
Optex Systems Holdings Inc. stock logo
OPXS
Optex Systems
$3.77M$0.7115.10N/A13.06%25.10%19.04%N/A
Precipio, Inc. stock logo
PRPO
Precipio
-$4.29M-$2.07N/AN/A-15.45%-25.87%-17.93%8/11/2025 (Estimated)

Latest PRPO, AKYA, OPXS, and OMIC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2025Q1 2025
Precipio, Inc. stock logo
PRPO
Precipio
N/A-$0.59N/A-$0.59N/A$4.93 million
5/13/2025Q2 2025
Optex Systems Holdings Inc. stock logo
OPXS
Optex Systems
N/A$0.26N/A$0.26N/A$10.73 million
5/12/2025Q1 2025
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
-$0.29-$0.32-$0.03-$0.32$20.19 million$16.64 million
3/27/2025Q4 2024
Precipio, Inc. stock logo
PRPO
Precipio
$0.74-$0.23-$0.97-$0.23$8.01 million$5.45 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
N/AN/AN/AN/AN/A
Singular Genomics Systems, Inc. stock logo
OMIC
Singular Genomics Systems
N/AN/AN/AN/AN/A
Optex Systems Holdings Inc. stock logo
OPXS
Optex Systems
N/AN/AN/AN/AN/A
Precipio, Inc. stock logo
PRPO
Precipio
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
10.12
0.61
0.40
Singular Genomics Systems, Inc. stock logo
OMIC
Singular Genomics Systems
0.04
7.37
6.67
Optex Systems Holdings Inc. stock logo
OPXS
Optex Systems
N/A
5.06
1.90
Precipio, Inc. stock logo
PRPO
Precipio
0.03
0.76
0.57

Institutional Ownership

CompanyInstitutional Ownership
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
79.42%
Singular Genomics Systems, Inc. stock logo
OMIC
Singular Genomics Systems
65.80%
Optex Systems Holdings Inc. stock logo
OPXS
Optex Systems
19.07%
Precipio, Inc. stock logo
PRPO
Precipio
10.45%

Insider Ownership

CompanyInsider Ownership
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
7.30%
Singular Genomics Systems, Inc. stock logo
OMIC
Singular Genomics Systems
22.20%
Optex Systems Holdings Inc. stock logo
OPXS
Optex Systems
30.30%
Precipio, Inc. stock logo
PRPO
Precipio
16.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Akoya Biosciences, Inc. stock logo
AKYA
Akoya Biosciences
9049.95 million46.31 millionOptionable
Singular Genomics Systems, Inc. stock logo
OMIC
Singular Genomics Systems
2202.54 million1.97 millionNo Data
Optex Systems Holdings Inc. stock logo
OPXS
Optex Systems
806.91 million4.82 millionNot Optionable
Precipio, Inc. stock logo
PRPO
Precipio
601.51 million1.26 millionNo Data

Recent News About These Companies

Precipio Announces its Q1-2025 Financial Results
Precipio trading halted, volatility trading pause
Precipio achieves positive adjusted EBITDA, cash flow in Q4

New MarketBeat Followers Over Time

Media Sentiment Over Time

Akoya Biosciences stock logo

Akoya Biosciences NASDAQ:AKYA

$1.26 -0.04 (-3.08%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$1.26 +0.00 (+0.40%)
As of 06/20/2025 05:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. It has a collaboration agreement with NeraCare that enables personalized therapy selection for early-stage melanoma patients. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

Singular Genomics Systems stock logo

Singular Genomics Systems NASDAQ:OMIC

$20.01 0.00 (0.00%)
As of 02/21/2025

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables for applications comprising single cell gene expression and proteomics, in situ RNA sequencing, and spatial RNA and proteomics applications for tissue. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California.

Optex Systems stock logo

Optex Systems NASDAQ:OPXS

$10.72 +0.37 (+3.57%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$10.70 -0.02 (-0.14%)
As of 06/20/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Optex Systems Holdings, Inc manufactures and sells optical sighting systems and assemblies primarily for the U.S. department of defense, foreign military applications, and commercial markets in the United States. It offers periscopes, such as laser and non-laser protected plastic and glass periscopes, electronic M17 day/thermal periscopes, and vision blocks; sighting systems, including back up sights, digital day and night sighting systems, M36 thermal periscope, unity mirrors, optical weapon system support and maintenance, commander weapon station sights, and sight assembly refurbishments; howitzers comprising M137 telescope, M187 mount, M119 aiming device, XM10 and aiming circles; and applied optics center consisting of laser interference filter, optical assemblies, laser filter units, day windows, and specialty thin film coatings, as well as other products, such as muzzle reference systems, binoculars, collimators, optical lenses and elements, and windows. The company also provides various periscope configurations, rifle and surveillance sights, and night vision optical assemblies. Its products are installed on various types of U.S. military land vehicles, such as the Abrams, Bradley, and Stryker families of fighting vehicles, as well as light armored and armored security vehicles. The company offers its products directly to the federal government, prime contractors, and foreign governments. Optex Systems Holdings, Inc was founded in 1987 and is headquartered in Richardson, Texas. Optex Systems Holdings, Inc is a subsidiary of Sileas Corporation.

Precipio stock logo

Precipio NASDAQ:PRPO

$11.51 +0.66 (+6.07%)
Closing price 06/20/2025 03:50 PM Eastern
Extended Trading
$11.18 -0.33 (-2.90%)
As of 06/20/2025 06:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.